R. Zhang

Triple combination of FDA-approved drugs including flufenamic acid, clarithromycin and zanamivir improves survival of severe influenza in mice

K. To, Kwok-Hung Chan, I. Hung, 2018, Archives of Virology.

A double-blind randomized phase 2 controlled trial of intradermal hepatitis B vaccination with a topical Toll-like receptor 7 agonist imiquimod, in patients on dialysis.

K. To, Kwok-Hung Chan, I. Hung, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial.

K. To, Kwok-Hung Chan, J. Chan, 2016, The Lancet. Infectious diseases.

Impact of SARS-CoV-2 variant-associated RBD mutations on the susceptibility to serum antibodies elicited by COVID-19 infection or vaccination.

K. To, A. Tam, C. Yip, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccines

O. Tsang, K. To, W. Leung, 2022, eBioMedicine.

Early treatment of high-risk hospitalized COVID-19 patients with a combination of interferon beta-1b and remdesivir: a phase 2 open-label randomized controlled trial

A. Tam, C. Yip, Kwok-Hung Chan, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

Kwok-Hung Chan, Raymond Liu, O. Tsang, 2020, The Lancet.

Angiotensin converting enzyme and sodium glucose cotransporter inhibitors alleviate inflammatory effects of SARS-CoV-2 in cardiomyocytes

Chun-Ka Wong, C. Siu, Kwok-Hung Chan, 2022, Cardiology journal.